< back



Primary Antibodies: Rockland’s Antibodies for cancer research are ideal in profiling proteins to identify candidate biomarkers, characterizing signaling pathways, and the measurement of changes in modification or expression level of cancer-related proteins. Antibodies have been characterized by Immunohistochemistry (IHC), Western Blot, IP, ELISA.                                                                                                                                         
Secondary Antibodies: DyLight™ Dye fluorescent Conjugates High fluorescence intensity and exeptional resistance to photobleaching Antibodies suitable for Fluorescence Microscopy, Flow Cytometry, ELISA, Western Blot, FRET-based Assays
     

Rockland Immunochemicals
Newsletter  Volume 27




BioConcept
Paradiesrain 14 Postfach 427
CH - 4123 Allschwil 1
Tel. +41 61 486 80 80
Fax +41 61 486 80 00
e-mail: info@bioconcept.ch


32